Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2003 Jun;80(2):189–200. doi: 10.1093/jurban/jtg022

Heroin overdose: Research and evidence-based intervention

Shane Darke 1,✉, Wayne Hall 2
PMCID: PMC3456279  PMID: 12791795

Abstract

Drug overdose is a major cause of premature death and morbidity among heroin users. This article examines recent research into heroin overdose to inform interventions that will reduce the rate of overdose death. The demographic characteristics of overdose cases are discussed, including factors associated with overdose: polydrug use, drug purity, drug tolerance, routes of administration, and suicide. Responses by heroin users at overdoses are also examined. Potential interventions to reduce the rate of overdose and overdose-related morbidity are examined in light of the emerging data in this field.

Keywords: Heroin, Mortality, Overdose

Full Text

The Full Text of this article is available as a PDF (81.5 KB).

References

  • 1.Fugelstad A, Annell A, Rajs J, Angren G. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatr Scand. 1997;96:169–175. doi: 10.1111/j.1600-0447.1997.tb10147.x. [DOI] [PubMed] [Google Scholar]
  • 2.Goldstein A, Herrara J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 1995;40:139–150. doi: 10.1016/0376-8716(95)01205-2. [DOI] [PubMed] [Google Scholar]
  • 3.Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22 year follow-up. Addiction. 1994;89:1299–1308. doi: 10.1111/j.1360-0443.1994.tb03309.x. [DOI] [PubMed] [Google Scholar]
  • 4.Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P. Study of 2708 heroin-related deaths in north-eastern Italy 1985–98 to establish main causes of death. Addiction. 2001;96:1127–1137. doi: 10.1046/j.1360-0443.2001.96811276.x. [DOI] [PubMed] [Google Scholar]
  • 5.Sanchez-Carbonell X, Seus L. Ten year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST project. Addiction. 2000;95:941–948. doi: 10.1046/j.1360-0443.2000.95694110.x. [DOI] [PubMed] [Google Scholar]
  • 6.Darke S, Zador D. Fatal heroin overdose: a review. Addiction. 1996;91:1765–1772. doi: 10.1111/j.1360-0443.1996.tb03800.x. [DOI] [PubMed] [Google Scholar]
  • 7.Sporer K. Acute heroin overdose. Ann Int Med. 1999;130:584–590. doi: 10.7326/0003-4819-130-7-199904060-00019. [DOI] [PubMed] [Google Scholar]
  • 8.Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96:1113–1125. doi: 10.1046/j.1360-0443.2001.96811135.x. [DOI] [PubMed] [Google Scholar]
  • 9.Centers for Disease Control Heroin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636. [PubMed] [Google Scholar]
  • 10.Centers for Disease Control Unintentional opiate overdose deaths—Kings County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49:636–640. [PubMed] [Google Scholar]
  • 11.Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26:453–460. doi: 10.1016/S0306-4603(00)00115-5. [DOI] [PubMed] [Google Scholar]
  • 12.O’Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Russell AE. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health. 2001;26:984–987. doi: 10.2105/ajph.91.6.984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hall W, Degenhardt L, Lynskey M. Trends in opioid overdose and suicide mortality in young adults in Australia 1964–1997. Med J Aust. 1999;171:34–37. doi: 10.5694/j.1326-5377.1999.tb123495.x. [DOI] [PubMed] [Google Scholar]
  • 14.Bennett G, Higgins D. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94:1179–1190. doi: 10.1046/j.1360-0443.1999.94811798.x. [DOI] [PubMed] [Google Scholar]
  • 15.Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia. I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411. doi: 10.1111/j.1360-0443.1996.tb02289.x. [DOI] [PubMed] [Google Scholar]
  • 16.Darke S, Ross J. Overdose risk perceptions and behaviours among heroin users in Sydney, Australia. Eur Addict Res. 1997;3:87–92. [Google Scholar]
  • 17.Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313:402–402. doi: 10.1136/bmj.313.7054.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.McGregor C, Darke S, Christie P, Ali R. Experience of non-fatal overdose among heroin users in Adelaide: circumstances and risk perception. Addiction. 1998;93:701–711. doi: 10.1046/j.1360-0443.1998.9357016.x. [DOI] [PubMed] [Google Scholar]
  • 19.Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction. 1999;94:71–82. doi: 10.1046/j.1360-0443.1999.941714.x. [DOI] [PubMed] [Google Scholar]
  • 20.Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95:687–695. doi: 10.1046/j.1360-0443.2000.9556874.x. [DOI] [PubMed] [Google Scholar]
  • 21.Cherubin C, McCusker J, Baden M, Kavaler F, Amsel Z. The epidemiology of death in narcotic addicts. Am J Epidemiol. 1972;96:11–22. doi: 10.1093/oxfordjournals.aje.a121428. [DOI] [PubMed] [Google Scholar]
  • 22.Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992–1996. Drug Alcohol Depend. 2000;60:141–150. doi: 10.1016/S0376-8716(99)00147-7. [DOI] [PubMed] [Google Scholar]
  • 23.Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKegany N. Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health. 1993;47:59–63. doi: 10.1136/jech.47.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hall W, Darke S. Trends in opiate overdose deaths in Australia, 1979–1995. Drug Alcohol Depend. 1998;52:71–77. doi: 10.1016/S0376-8716(98)00044-1. [DOI] [PubMed] [Google Scholar]
  • 25.McGregor C, Ali R, Lokan R, Christie P, Darke S. Accidental fatalities among heroin users in South Australia, 1994–1997: toxicological findings and circumstances of death. Addict Res. 2002;26:335–346. doi: 10.1080/1606635021000010261. [DOI] [Google Scholar]
  • 26.Zador D, Sunjic S, Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996;164:204–207. doi: 10.5694/j.1326-5377.1996.tb94136.x. [DOI] [PubMed] [Google Scholar]
  • 27.Harlow KC. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976–1987. Public Health Rep. 1990;195:455–462. [PMC free article] [PubMed] [Google Scholar]
  • 28.Ruttenber AJ, Luke JL. Heroin-related deaths: new epidemiologic insights. Science. 1984;226:14–20. doi: 10.1126/science.6474188. [DOI] [PubMed] [Google Scholar]
  • 29.Caplehorn JRM, Dalton SYN, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts’ risk of death. Addiction. 1994;89:203–207. doi: 10.1111/j.1360-0443.1994.tb00879.x. [DOI] [PubMed] [Google Scholar]
  • 30.Davoli M, Perucci CA, Forastiere F, et al. Risk factors for overdose mortality: a case control study within a cohort of intravenous drug users. Int J Epidemiol. 1993;22:273–277. doi: 10.1093/ije/22.2.273. [DOI] [PubMed] [Google Scholar]
  • 31.Fugelstad A, Rajs J, DeVerdier MG. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction. 1995;90:711–716. doi: 10.1111/j.1360-0443.1995.tb02209.x. [DOI] [PubMed] [Google Scholar]
  • 32.Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS) J Subst Abuse Treat. 2002;22:1–9. doi: 10.1016/S0740-5472(01)00206-9. [DOI] [PubMed] [Google Scholar]
  • 33.Goldberger BA, Cone EJ, Grant TM, Caplan YH, Levine BS, Smialek JE. Disposition of heroin and its metabolites in heroin related deaths. J Anal Toxicol. 1994;18:22–28. doi: 10.1093/jat/18.1.22. [DOI] [PubMed] [Google Scholar]
  • 34.Monforte JR. Some observations concerning blood morphine concentrations in narcotic addicts. J Forensic Sci. 1977;22:718–724. [PubMed] [Google Scholar]
  • 35.Risser D, Honigschnabl S, Stichenwirth M, et al. Drug-related emergencies and drug-related deaths in Vienna, 1995–1997. Drug Alcohol Depend. 2001;61:307–313. doi: 10.1016/S0376-8716(00)00150-2. [DOI] [PubMed] [Google Scholar]
  • 36.Steentoft A, Worm K, Christenson H. Morphine concentrations in autopsy material from fatal cases after intake of morphine and/or heroin. J Forensic Sci Soc. 1988;28:87–94. doi: 10.1016/S0015-7368(88)72812-1. [DOI] [PubMed] [Google Scholar]
  • 37.Gutierrez-Cebollada J, Torre R, Ortuno J, Garces J, Cami J. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend. 1994;35:169–174. doi: 10.1016/0376-8716(94)90124-4. [DOI] [PubMed] [Google Scholar]
  • 38.Ruttenber AJ, Kalter HO, Santinga P. The role of ethanol abuse in the etiology of heroin-related death. J Forensic Sci. 1990;35:891–900. [PubMed] [Google Scholar]
  • 39.Caplehorn J. Risk factors for non-HIV-related deaths among methadone maintenance patients. Eur Addict Res. 1996;2:49–52. [Google Scholar]
  • 40.Richards RG, Reed D, Cravey RH. Death from intravenously administered narcotics: a study of 114 cases. J Forensic Sci. 1976;21:467–482. [PubMed] [Google Scholar]
  • 41.Darke S, Ross J. The use of antidepressants among injecting drug users in Sydney, Australia. Addiction. 2000;95:407–417. doi: 10.1046/j.1360-0443.2000.95340711.x. [DOI] [PubMed] [Google Scholar]
  • 42.Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54:155–161. doi: 10.1016/S0376-8716(98)00159-8. [DOI] [PubMed] [Google Scholar]
  • 43.Desmond DP, Maddux JF, Trevino A. Street heroin potency and deaths from overdose in San Antonio. Am J Drug Alcohol Abuse. 1978;5:39–49. doi: 10.3109/00952997809029259. [DOI] [PubMed] [Google Scholar]
  • 44.Risser D, Uhl A, Stichenwirth M, et al. Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction. 2000;95:375–382. doi: 10.1046/j.1360-0443.2000.9533758.x. [DOI] [PubMed] [Google Scholar]
  • 45.Coomber R. How often does the adulteration/dilution of heroin actually occur? An analysis of 228 “street” heroin samples across the UK (1995–96) and discussion of monitoring policy. Int J Durg Policy. 1997;8:178–186. [Google Scholar]
  • 46.Coomber R. The cutting of heroin in the United States in the 1990s. J Drug Issues. 1999;29:17–36. [Google Scholar]
  • 47.Maher L, Swift W, Dawson M. Heroin purity and composition in Sydney, Australia. Drug Alcohol Rev. 2001;20:439–448. doi: 10.1080/09595230120092698. [DOI] [Google Scholar]
  • 48.Darke S, Sunjic S, Zador D, Prolov T. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 1997;47:45–53. doi: 10.1016/S0376-8716(97)00070-7. [DOI] [PubMed] [Google Scholar]
  • 49.Kintz P, Mangin P, Lugnier AA, Chaumont AJ. Toxicological data after heroin overdose. Hum Toxicol. 1989;8:487–489. doi: 10.1177/096032718900800609. [DOI] [PubMed] [Google Scholar]
  • 50.Darke S, Hall W, Kaye S, Ross J, Duflou J. Hair morphine concentrations of fatal heroin overdose cases and living heroin users. Addiction. 2002;97:977–984. doi: 10.1046/j.1360-0443.2002.00148.x. [DOI] [PubMed] [Google Scholar]
  • 51.Tagliaro F, Debattisti Z, Smith FP, Marigo M. Death from heroin overdose: findings from hair analysis. Lancet. 1998;351:1923–1925. doi: 10.1016/S0140-6736(97)10101-5. [DOI] [PubMed] [Google Scholar]
  • 52.Kronstrand R, Grundin R, Jonsson J. Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose. Forensic Sci Int. 1998;92:29–38. doi: 10.1016/S0379-0738(98)00003-6. [DOI] [PubMed] [Google Scholar]
  • 53.Darke S, Kaye S, Finlay-Jones R. Drug use and injection risk-taking among prison methadone maintenance patients. Addiction. 1998;93:1169–1175. doi: 10.1046/j.1360-0443.1998.93811695.x. [DOI] [PubMed] [Google Scholar]
  • 54.Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316:426–428. doi: 10.1136/bmj.316.7129.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Seymour A, Oliver JS, Black M. Drug-related deaths among recently released prisoners in the Strathelyde region of Scotland. J Forensic Sci. 2000;45:649–654. [PubMed] [Google Scholar]
  • 56.Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict. 1999;8:148–160. doi: 10.1080/105504999305956. [DOI] [PubMed] [Google Scholar]
  • 57.Neaigus A, Miller M, Friedman S, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96:847–860. doi: 10.1046/j.1360-0443.2001.9668476.x. [DOI] [PubMed] [Google Scholar]
  • 58.Perez-Jimenez JP, Robert MS. Transitions in the route of heroin use. Eur Addict Res. 1997;3:93–98. doi: 10.1159/000259157. [DOI] [Google Scholar]
  • 59.Darke S, Ross J. Fatal heroin overdoses resulting from non-injecting routes of administration, NSW, Australia, 1992–1996. Addiction. 2000;95:596–599. doi: 10.1046/j.1360-0443.2000.9545698.x. [DOI] [PubMed] [Google Scholar]
  • 60.Dinwiddie SH, Reich T, Cloninger CR. Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry. 1992;53:364–369. [PubMed] [Google Scholar]
  • 61.Darke S, Ross J. Poly drug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48:135–141. doi: 10.1016/S0376-8716(97)00117-8. [DOI] [PubMed] [Google Scholar]
  • 62.Kosten TR, Rounsaville BJ. Suicidality among opioid addicts: a 2.5 year follow-up. Am J Drug Alcohol Abuse. 1998;14:357–369. doi: 10.3109/00952998809001557. [DOI] [PubMed] [Google Scholar]
  • 63.Hulse GK, English DR, Milne E, Holman CDJ. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94:221–229. doi: 10.1046/j.1360-0443.1999.9422216.x. [DOI] [PubMed] [Google Scholar]
  • 64.Neale J. Suicidal intent in non-fatal illicit drug overdose. Addiction. 2000;95:85–93. doi: 10.1046/j.1360-0443.2000.951859.x. [DOI] [PubMed] [Google Scholar]
  • 65.Rossow I, Lauritzen G. Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction. 1999;94:209–219. doi: 10.1046/j.1360-0443.1999.9422095.x. [DOI] [PubMed] [Google Scholar]
  • 66.Darke S, Ross J. The relationship between suicide and overdose among methadone maintenance patients in Sydney, Australia. Addiction. 2001;96:1443–1453. doi: 10.1046/j.1360-0443.2001.961014438.x. [DOI] [PubMed] [Google Scholar]
  • 67.Kjelsberg E, Winther M, Dahl AA. Overdose deaths in young substance abusers: accidents or hidden suicides. Acta Psychiatr Scand. 1995;91:236–242. doi: 10.1111/j.1600-0447.1995.tb09775.x. [DOI] [PubMed] [Google Scholar]
  • 68.Darke S, Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction. 2002;97:1383–1394. doi: 10.1046/j.1360-0443.2002.00214.x. [DOI] [PubMed] [Google Scholar]
  • 69.Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia. II. Responses to overdose. Addiction. 1996;91:413–417. doi: 10.1111/j.1360-0443.1996.tb02290.x. [DOI] [PubMed] [Google Scholar]
  • 70.Strang J, Best D, Man L, Noble A, Gossop M. Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation. Int J Drug Policy. 2000;11:437–445. doi: 10.1016/S0955-3959(00)00070-0. [DOI] [PubMed] [Google Scholar]
  • 71.Manning FJ, Ingraham LH, Derouin EM, Vaughn MS, Kukura FC, St Michel GR. Drug “overdoses” among US soldiers in Europe, 1978–1979. II. Psychological autopsies following deaths and near-deaths. Int J Addict. 1983;18:153–156. doi: 10.3109/10826088309027349. [DOI] [PubMed] [Google Scholar]
  • 72.Garriot JC, Sturner WQ. Morphine concentrations and survival periods in acute heroin fatalities. N Engl J Med. 1973;289:1276–1278. doi: 10.1056/NEJM197312132892404. [DOI] [PubMed] [Google Scholar]
  • 73.Nakamura GR. Toxicological assessments in acute heroin fatalities. Clin Toxicol. 1978;13:75–87. doi: 10.3109/15563657808988229. [DOI] [PubMed] [Google Scholar]
  • 74.Bammer G, Sengoz A. Non-fatal heroin overdoses. Med J Aust. 1994;161:572–573. doi: 10.5694/j.1326-5377.1994.tb127616.x. [DOI] [PubMed] [Google Scholar]
  • 75.McGregor C, Ali R, Christie P, Darke S. Overdose among heroin users: evaluation of an intervention in South Australia. Addict Res. 2001;9:481–501. [Google Scholar]
  • 76.Darke S, Hall W. The distribution of naloxone to heroin users. Addiction. 1997;92:1195–1199. doi: 10.1111/j.1360-0443.1997.tb03681.x. [DOI] [PubMed] [Google Scholar]
  • 77.Lenton S, Hargreaves K. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263. doi: 10.5694/j.1326-5377.2000.tb125633.x. [DOI] [PubMed] [Google Scholar]
  • 78.Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: is there a case for takehome naloxone? BMJ. 1996;312:1435–1435. doi: 10.1136/bmj.312.7044.1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Proventing and curtailing injecting drug use: a review of opportunities for developing and delivering “route transition interventions”. Drug Alcohol Rev. 1999;18:441–445. doi: 10.1080/09595239996310. [DOI] [Google Scholar]
  • 80.Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000;337–346.
  • 81.Kemmesies UE. The Open Drug Scene and the Safe Injection Rooms Offers in Frankfurt am Main 1995. Frankfurt, Germany: Stadt Frankfurt/Dezernat Frauen und Gesundheit; 1999. [Google Scholar]
  • 82.Poschadel S, Hoger R, Schnitzler J, Schreckenberg D. Evaluation der Arbeit der Drogenkonsumraume in der Bundesrepublik Deutschland. Bochum, Germany: ZEUS GmbH; 2002. [Google Scholar]
  • 83.Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation for alley-rooms I, II and II in Basel. Soc Prev Med. 1996;S58–S68. [DOI] [PubMed]
  • 84.Rehm J, Gschwend P, Steffen T, Gutzwiller F, Dobler-Mikola A, Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription. Lancet. 2001;358:1417–1420. doi: 10.1016/S0140-6736(01)06529-1. [DOI] [PubMed] [Google Scholar]
  • 85.Hall W. Assessing the Population-Level Impact of the Swiss Model of Heroin Prescribing. Sydney, Australia: University of New South Wales, Sydney; 1999. [Google Scholar]
  • 86.Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction. 2002;97:963–967. doi: 10.1046/j.1360-0443.2002.00132.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES